Altogether, these results confirmed that the CHREBP/cyclin D1 axis could regulate GC progression via the Rb/E2F1 pathway, the activation of which has been elaborated to promote G1/S transition and enhance tumor cells proliferation [35]. Here, E2F1 is linked to neoplasm.